Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Protein S.

Artykuły w czasopismach na temat „Protein S”

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Protein S”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Sorice, M., T. Griggi, A. Circella, et al. "Protein S antibodies in acquired protein S deficiencies [letter]." Blood 83, no. 8 (1994): 2383–84. http://dx.doi.org/10.1182/blood.v83.8.2383b.2383b.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Sorice, M., T. Griggi, A. Circella, et al. "Protein S antibodies in acquired protein S deficiencies [letter]." Blood 83, no. 8 (1994): 2383–84. http://dx.doi.org/10.1182/blood.v83.8.2383b.bloodjournal8382383b.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Sacchi, E., M. Pinotti, G. Marchetti, et al. "Protein S mRNA in Patients with Protein S Deficiency." Thrombosis and Haemostasis 73, no. 05 (1995): 746–49. http://dx.doi.org/10.1055/s-0038-1653862.

Pełny tekst źródła
Streszczenie:
SummaryA protein S gene polymorphism, detectable by restriction analysis (BstXI) of amplified exonic sequences (exon 15), was studied in seven Italian families with protein S deficiency. In the 17 individuals heterozygous for the polymorphism the study was extended to platelet mRNA through reverse transcription, amplification and densitometric analysis. mRNA produced by the putative defective protein S genes was absent in three families and reduced to a different extent (as expressed by altered allelic ratios) in four families. The allelic ratios helped to distinguish total protein S deficienc
Style APA, Harvard, Vancouver, ISO itp.
4

Kwaan, Hau. "Protein C and Protein S." Seminars in Thrombosis and Hemostasis 15, no. 03 (1989): 353–55. http://dx.doi.org/10.1055/s-2007-1002728.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Esmon, Charles T. "Protein S and protein C." Trends in Cardiovascular Medicine 2, no. 6 (1992): 214–19. http://dx.doi.org/10.1016/1050-1738(92)90027-p.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Rick, Margaret E. "Protein C and Protein S." JAMA 263, no. 5 (1990): 701. http://dx.doi.org/10.1001/jama.1990.03440050095041.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Nelson, R. M., and G. L. Long. "Binding of protein S to C4b-binding protein. Mutagenesis of protein S." Journal of Biological Chemistry 267, no. 12 (1992): 8140–45. http://dx.doi.org/10.1016/s0021-9258(18)42418-0.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Bertina, R. M., A. van Wijngaarden, J. Reinalda-Poot, S. R. Poort, and V. J. J. Bom. "Determination of Plasma Protein S - The Protein Cofactor of Activated Protein C." Thrombosis and Haemostasis 53, no. 02 (1985): 268–72. http://dx.doi.org/10.1055/s-0038-1661291.

Pełny tekst źródła
Streszczenie:
SummaryProtein S, an important cofactor of activated protein C, and C4b-binding protein were purified from human plasma. Specific antibodies against the purified proteins were raised in rabbits and used for the development of immunologic assays for these proteins in plasma: an immunoradiometric assay for protein S (which measures both free protein S and protein S complexed with C4b-binding protein) and an electroimmunoassay for C4b- binding protein. Ranges for the concentrations of these proteins were established in healthy volunteers and patients using oral anticoagulant therapy. A slight dec
Style APA, Harvard, Vancouver, ISO itp.
9

NAKAYAMA, Takayuki, and Tetsuhito KOJIMA. "Protein S Deficiency." Japanese Journal of Thrombosis and Hemostasis 12, no. 3 (2001): 235–39. http://dx.doi.org/10.2491/jjsth.12.235.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Zhang, Mingzi M., and Howard C. Hang. "Protein S-palmitoylation in cellular differentiation." Biochemical Society Transactions 45, no. 1 (2017): 275–85. http://dx.doi.org/10.1042/bst20160236.

Pełny tekst źródła
Streszczenie:
Reversible protein S-palmitoylation confers spatiotemporal control of protein function by modulating protein stability, trafficking and activity, as well as protein–protein and membrane–protein associations. Enabled by technological advances, global studies revealed S-palmitoylation to be an important and pervasive posttranslational modification in eukaryotes with the potential to coordinate diverse biological processes as cells transition from one state to another. Here, we review the strategies and tools to analyze in vivo protein palmitoylation and interrogate the functions of the enzymes t
Style APA, Harvard, Vancouver, ISO itp.
11

Ratnaparkhi, Girish S., Satish Kumar Awasthi, P. Rani, P. Balaram та R. Varadarajan. "Structural and thermodynamic consequences of introducing α-aminoisobutyric acid in the S peptide of ribonuclease S". Protein Engineering, Design and Selection 13, № 10 (2000): 697–702. http://dx.doi.org/10.1093/protein/13.10.697.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
12

Ruoppolo, Margherita, and Robert B. Freedman. "Protein-S-S-Glutathione Mixed Disulfides as Models of Unfolded Proteins." Biochemistry 33, no. 24 (1994): 7654–62. http://dx.doi.org/10.1021/bi00190a020.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
13

D'Angelo, A., and S. Vigano D'Angelo. "Protein S deficiency." Haematologica 93, no. 4 (2008): 498–501. http://dx.doi.org/10.3324/haematol.12691.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
14

Borgel, Delphine, Sophie Gandrille, and Martine Aiach. "Protein S Deficiency." Thrombosis and Haemostasis 78, no. 01 (1997): 351–56. http://dx.doi.org/10.1055/s-0038-1657551.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
15

Meissner, W., H. Fritz, Th Deufel, B. Dohrn, A. Meier-Hellmann, and K. Reinhart. "S-100 PROTEIN." Critical Care Medicine 26, Supplement (1998): 83A. http://dx.doi.org/10.1097/00003246-199801001-00213.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
16

Van Cott, Elizabeth M., Marlies Ledford-Kraemer, Piet Meijer, William L. Nichols, Stephen M. Johnson, and Ellinor I. B. Peerschke. "Protein S Assays." American Journal of Clinical Pathology 123, no. 5 (2005): 778–85. http://dx.doi.org/10.1309/bg1gr3anar9905f4.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
17

Chamberlain, Luke H., and Michael J. Shipston. "The Physiology of Protein S-acylation." Physiological Reviews 95, no. 2 (2015): 341–76. http://dx.doi.org/10.1152/physrev.00032.2014.

Pełny tekst źródła
Streszczenie:
Protein S-acylation, the only fully reversible posttranslational lipid modification of proteins, is emerging as a ubiquitous mechanism to control the properties and function of a diverse array of proteins and consequently physiological processes. S-acylation results from the enzymatic addition of long-chain lipids, most typically palmitate, onto intracellular cysteine residues of soluble and transmembrane proteins via a labile thioester linkage. Addition of lipid results in increases in protein hydrophobicity that can impact on protein structure, assembly, maturation, trafficking, and function
Style APA, Harvard, Vancouver, ISO itp.
18

Dolan, G., J. Ball, and F. E. Preston. "10 Protein C and protein S." Baillière's Clinical Haematology 2, no. 4 (1989): 999–1042. http://dx.doi.org/10.1016/s0950-3536(89)80055-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
19

MIYATA, Toshiyuki, Jun MIZUGUCHI, Atsuo SUZUKI, and Tetsuhito KOJIMA. "Basics of protein C and protein S." Japanese Journal of Thrombosis and Hemostasis 25, no. 1 (2014): 40–47. http://dx.doi.org/10.2491/jjsth.25.40.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
20

Zhang, Jing, Yongxiang Wang, Shuwen Fu, et al. "Role of Small Envelope Protein in Sustaining the Intracellular and Extracellular Levels of Hepatitis B Virus Large and Middle Envelope Proteins." Viruses 13, no. 4 (2021): 613. http://dx.doi.org/10.3390/v13040613.

Pełny tekst źródła
Streszczenie:
Hepatitis B virus (HBV) expresses co-terminal large (L), middle (M), and small (S) envelope proteins. S protein drives virion and subviral particle secretion, whereas L protein inhibits subviral particle secretion but coordinates virion morphogenesis. We previously found that preventing S protein expression from a subgenomic construct eliminated M protein. The present study further examined impact of S protein on L and M proteins. Mutations were introduced to subgenomic construct of genotype A or 1.1 mer replication construct of genotype A or D, and viral proteins were analyzed from transfecte
Style APA, Harvard, Vancouver, ISO itp.
21

Breitwieser, Andreas, Philipp Siedlaczek, Helga Lichtenegger, Uwe B. Sleytr, and Dietmar Pum. "S-Layer Protein Coated Carbon Nanotubes." Coatings 9, no. 8 (2019): 492. http://dx.doi.org/10.3390/coatings9080492.

Pełny tekst źródła
Streszczenie:
Carbon nanotubes (CNTs) have already been considered for medical applications due to their small diameter and ability to penetrate cells and tissues. However, since CNTs are chemically inert and non-dispersible in water, they have to be chemically functionalized or coated with biomolecules to carry payloads or interact with the environment. Proteins, although often only randomly bound to the CNT surface, are preferred because they provide a better biocompatibility and present functional groups for binding additional molecules. A new approach to functionalize CNTs with a closed and precisely or
Style APA, Harvard, Vancouver, ISO itp.
22

Huoponen, Outi, Jukka Partanen, Vesa Rasi, Tom Krusius, and Tuuli Heinikari. "Protein S gene polymorphisms Pro626 and nt2698 – no correlation to free protein S levels or protein S activities." Thrombosis and Haemostasis 94, no. 12 (2005): 1340–41. http://dx.doi.org/10.1160/th05-06-1340.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
23

Schwarz, HP, W. Muntean, H. Watzke, B. Richter, and JH Griffin. "Low total protein S antigen but high protein S activity due to decreased C4b-binding protein in neonates." Blood 71, no. 3 (1988): 562–65. http://dx.doi.org/10.1182/blood.v71.3.562.562.

Pełny tekst źródła
Streszczenie:
Abstract Protein S, a vitamin K-dependent cofactor for activated protein C, exists in normal adult plasma in a free anticoagulantly active form and in an inactive form complexed to C4b-binding protein. Immunologic and functional levels of protein S and C4b-binding protein in plasma were determined for 20 newborn infants and compared with adult normal pooled plasma. Total protein S antigen levels averaged 23%, similar to other vitamin K-dependent plasma proteins. However, the protein S anticoagulant activity was 74% of that of adult normal plasma. This apparent discrepancy of activity to antige
Style APA, Harvard, Vancouver, ISO itp.
24

Schwarz, HP, W. Muntean, H. Watzke, B. Richter, and JH Griffin. "Low total protein S antigen but high protein S activity due to decreased C4b-binding protein in neonates." Blood 71, no. 3 (1988): 562–65. http://dx.doi.org/10.1182/blood.v71.3.562.bloodjournal713562.

Pełny tekst źródła
Streszczenie:
Protein S, a vitamin K-dependent cofactor for activated protein C, exists in normal adult plasma in a free anticoagulantly active form and in an inactive form complexed to C4b-binding protein. Immunologic and functional levels of protein S and C4b-binding protein in plasma were determined for 20 newborn infants and compared with adult normal pooled plasma. Total protein S antigen levels averaged 23%, similar to other vitamin K-dependent plasma proteins. However, the protein S anticoagulant activity was 74% of that of adult normal plasma. This apparent discrepancy of activity to antigen was sho
Style APA, Harvard, Vancouver, ISO itp.
25

Hillarp, Andreas, Björn Dahlbäck, and Kristina Persson. "Analytical Considerations for Free Protein S Assays in Protein S Deficiency." Thrombosis and Haemostasis 86, no. 11 (2001): 1144–47. http://dx.doi.org/10.1055/s-0037-1616042.

Pełny tekst źródła
Streszczenie:
SummaryProtein S is an anticoagulant protein that circulates in plasma in complex with C4b-binding protein (C4BP) or in free form. Deficiency of protein S increases the risk of venous thrombosis. Measurement of free protein S, as compared to total levels, has been shown to be superior for prediction of protein S deficiency. We studied the effects of different handling protocols for an immuno- and a ligand (C4BP)-based assay for free protein S. When the assay was performed at 37° C, the levels of free protein S in plasma from protein S deficient patients were approximately twice those obtained
Style APA, Harvard, Vancouver, ISO itp.
26

Huisveld, I. A., J. E. H. Hospers, J. C. M. Meijers, A. E. Starkenburg, W. B. M. Erich, and B. N. Bouma. "Oral contraceptives reduce total protein S, but not free protein S." Thrombosis Research 45, no. 1 (1987): 109–14. http://dx.doi.org/10.1016/0049-3848(87)90262-3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
27

Rodger, Marc A., Marc Carrier, Muriel Gervais, and Gail Rock. "Normal Functional Protein S Activity Does Not Exclude Protein S Deficiency." Pathophysiology of Haemostasis and Thrombosis 33, no. 4 (2003): 202–5. http://dx.doi.org/10.1159/000081509.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
28

Einarson, M. B., E. N. Pugacheva, and J. R. Orlinick. "Identification of Protein-Protein Interactions with Glutathione-S-Transferase (GST) Fusion Proteins." Cold Spring Harbor Protocols 2007, no. 8 (2007): pdb.top11. http://dx.doi.org/10.1101/pdb.top11.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
29

Kordyukova, Larisa V., Marina V. Serebryakova, Vladislav V. Khrustalev, and Michael Veit. "Differential S-acylation of Enveloped Viruses." Protein & Peptide Letters 26, no. 8 (2019): 588–600. http://dx.doi.org/10.2174/0929866526666190603082521.

Pełny tekst źródła
Streszczenie:
Post-translational modifications often regulate protein functioning. Covalent attachment of long chain fatty acids to cysteine residues via a thioester linkage (known as protein palmitoylation or S-acylation) affects protein trafficking, protein-protein and protein-membrane interactions. This post-translational modification is coupled to membrane fusion or virus assembly and may affect viral replication in vitro and thus also virus pathogenesis in vivo. In this review we outline modern methods to study S-acylation of viral proteins and to characterize palmitoylproteomes of virus infected cells
Style APA, Harvard, Vancouver, ISO itp.
30

Graziano, Giuseppe, Francesca Catanzano, Concetta Giancola, and Guido Barone. "DSC Study of the Thermal Stability of S-Protein and S-Peptide/S-Protein Complexes†." Biochemistry 35, no. 41 (1996): 13386–92. http://dx.doi.org/10.1021/bi960856+.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
31

Zhang, Yan, Elise R. Lyver, Eiko Nakamaru-Ogiso, et al. "Dre2, a Conserved Eukaryotic Fe/S Cluster Protein, Functions in Cytosolic Fe/S Protein Biogenesis." Molecular and Cellular Biology 28, no. 18 (2008): 5569–82. http://dx.doi.org/10.1128/mcb.00642-08.

Pełny tekst źródła
Streszczenie:
ABSTRACT In a forward genetic screen for interaction with mitochondrial iron carrier proteins in Saccharomyces cerevisiae, a hypomorphic mutation of the essential DRE2 gene was found to confer lethality when combined with Δmrs3 and Δmrs4. The dre2 mutant or Dre2-depleted cells were deficient in cytosolic Fe/S cluster protein activities while maintaining mitochondrial Fe/S clusters. The Dre2 amino acid sequence was evolutionarily conserved, and cysteine motifs (CX2CXC and twin CX2C) in human and yeast proteins were perfectly aligned. The human Dre2 homolog (implicated in blocking apoptosis and
Style APA, Harvard, Vancouver, ISO itp.
32

Brugge, Jeroen, Guido Tans, Jan Rosing, and Elisabetta Castoldi. "Protein S levels modulate the activated protein C resistance phenotype induced by elevated prothrombin levels." Thrombosis and Haemostasis 95, no. 02 (2006): 236–42. http://dx.doi.org/10.1160/th05-08-0582.

Pełny tekst źródła
Streszczenie:
SummaryElevated plasma prothrombin levels, due to the prothrombin 20210 G/A mutation or to acquired causes, area risk factor for venous thrombosis,partly because of prothrombin-mediated inhibition of the protein C anticoagulant pathway and consequent activated proteinC (APC) resistance. We determined the effect of plasma prothrombin concentration on the APC resistance phenotype and evaluated the role of protein S levels asa modulating variable. The effect of prothrombin and protein S levels on APC resistance was investigated in reconstituted plasma systems and in a population of healthy indivi
Style APA, Harvard, Vancouver, ISO itp.
33

Ju, Yun-Jin, Hye-Won Lee, Ji-Woong Choi, and Min-Sik Choi. "The Role of Protein S-Nitrosylation in Protein Misfolding-Associated Diseases." Life 11, no. 7 (2021): 705. http://dx.doi.org/10.3390/life11070705.

Pełny tekst źródła
Streszczenie:
Abnormal and excessive nitrosative stress contributes to neurodegenerative disease associated with the production of pathological levels of misfolded proteins. The accumulated findings strongly suggest that excessive NO production can induce and deepen these pathological processes, particularly by the S-nitrosylation of target proteins. Therefore, the relationship between S-nitrosylated proteins and the accumulation of misfolded proteins was reviewed. We particularly focused on the S-nitrosylation of E3-ubiquitin-protein ligase, parkin, and endoplasmic reticulum chaperone, PDI, which contribut
Style APA, Harvard, Vancouver, ISO itp.
34

Teulieres, Chantal, Gilbert Alibert, and Raoul Ranjeva. "Reversible phosphorylation of tonoplast proteins involves tonoplast-bound calcium-calmodulin-dependent protein kinase(s) and protein phosphatase(s)." Plant Cell Reports 4, no. 4 (1985): 199–201. http://dx.doi.org/10.1007/bf00269288.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
35

Lush, C. J., L. Armstrong, and V. E. Mitchell. "Free Protein S and C4b Binding Protein." American Journal of Clinical Pathology 96, no. 3 (1991): 434–38. http://dx.doi.org/10.1093/ajcp/96.3.434.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
36

Kessler, Craig M., and Dudley K. Strickland. "Protein C and protein S clinical perspectives." Clinica Chimica Acta 170, no. 1 (1987): 25–36. http://dx.doi.org/10.1016/0009-8981(87)90380-9.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
37

Hopmeier, P. "Mangelzustände an Antithrombin III, Protein C und Protein S." Hämostaseologie 13, no. 04 (1993): 152–56. http://dx.doi.org/10.1055/s-0038-1655229.

Pełny tekst źródła
Streszczenie:
ZusammenfassungMangelzustände an Antithrombin III, Protein C und Protein S sind vielfach mit einem erhöhten Thromboembolierisiko verbunden. Klinische Manifestationen sind beim Antithrombin-Ill-Mangel vorwiegend tiefe Venenthrombosen, während beim Protein-Cund Protein-S-Mangel auch arterielle Verschlüsse vereinzelt Vorkommen. Die Diagnose dieser Mangelzustände ist durch Routinetests heute einfach und zuverlässig möglich. Hingegen ist ein positiver Befund bei Personen mit unauffälliger Anamnese schwierig zu interpretieren. Besonders beim Protein-C-/Protein-S-System dürften ein oder mehrere noch
Style APA, Harvard, Vancouver, ISO itp.
38

KAMIYA, Tadashi. "Protein S and thromboembolism." Blood & Vessel 17, no. 2 (1986): 89–98. http://dx.doi.org/10.2491/jjsth1970.17.89.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
39

NOMURA, MASAKAZU, and HIDEYUKI YAMADA. "Sericin/Protein Powder S." Sen'i Gakkaishi 48, no. 6 (1992): P305—P306. http://dx.doi.org/10.2115/fiber.48.6_p305.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
40

Hafizi, Sassan, and Björn Dahlbäck. "Gas6 and protein S." FEBS Journal 273, no. 23 (2006): 5231–44. http://dx.doi.org/10.1111/j.1742-4658.2006.05529.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
41

Bertina, R. M. "Hereditary Protein S Deficiency." Pathophysiology of Haemostasis and Thrombosis 15, no. 4 (1985): 241–46. http://dx.doi.org/10.1159/000215155.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
42

Kennedy, C. R. "Acquired protein S deficiency." Archives of Disease in Childhood 69, no. 2 (1993): 265. http://dx.doi.org/10.1136/adc.69.2.265.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
43

Bissuel, Fran??ois, Micheline Berruyer, Xavier Causse, Marc Dechavanne, and Christian Trepo. "Acquired Protein S Deficiency." JAIDS Journal of Acquired Immune Deficiency Syndromes 5, no. 5 (1992): 484???489. http://dx.doi.org/10.1097/00126334-199205000-00009.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
44

Simmonds, RE, H. Ireland, G. Kunz, and DA Lane. "Identification of 19 protein S gene mutations in patients with phenotypic protein S deficiency and thrombosis. Protein S Study Group." Blood 88, no. 11 (1996): 4195–204. http://dx.doi.org/10.1182/blood.v88.11.4195.4195.

Pełny tekst źródła
Streszczenie:
Abstract Protein S is a protein C-dependent and independent inhibitor of the coagulation cascade. Deficiency of protein S is an established risk factor for venous thromboembolism. We have used a strategy of specific amplification of the coding regions and intron/exon boundaries of the active protein S gene (PROS1) and direct single-strand solid phase sequencing, to seek mutations in 35 individuals with phenotypic protein S deficiency. Nineteen point mutations (16 novel) in 19 probands (or relatives of probands) with venous thromboembolism are reported here. Fifteen of the 19 mutations were exp
Style APA, Harvard, Vancouver, ISO itp.
45

Simmonds, RE, H. Ireland, G. Kunz, and DA Lane. "Identification of 19 protein S gene mutations in patients with phenotypic protein S deficiency and thrombosis. Protein S Study Group." Blood 88, no. 11 (1996): 4195–204. http://dx.doi.org/10.1182/blood.v88.11.4195.bloodjournal88114195.

Pełny tekst źródła
Streszczenie:
Protein S is a protein C-dependent and independent inhibitor of the coagulation cascade. Deficiency of protein S is an established risk factor for venous thromboembolism. We have used a strategy of specific amplification of the coding regions and intron/exon boundaries of the active protein S gene (PROS1) and direct single-strand solid phase sequencing, to seek mutations in 35 individuals with phenotypic protein S deficiency. Nineteen point mutations (16 novel) in 19 probands (or relatives of probands) with venous thromboembolism are reported here. Fifteen of the 19 mutations were expected to
Style APA, Harvard, Vancouver, ISO itp.
46

Nguyen-Mau, Sao-Mai, So-Young Oh, Daphne I. Schneewind, Dominique Missiakas, and Olaf Schneewind. "Bacillus anthracis SlaQ Promotes S-Layer Protein Assembly." Journal of Bacteriology 197, no. 19 (2015): 3216–27. http://dx.doi.org/10.1128/jb.00492-15.

Pełny tekst źródła
Streszczenie:
ABSTRACTBacillus anthracisvegetative forms assemble an S-layer comprised of two S-layer proteins, Sap and EA1. A hallmark of S-layer proteins are their C-terminal crystallization domains, which assemble into a crystalline lattice once these polypeptides are deposited on the bacterial surface via association between their N-terminal S-layer homology domains and the secondary cell wall polysaccharide. Here we show thatslaQ, encoding a small cytoplasmic protein conserved among pathogenic bacilli elaborating S-layers, is required for the efficient secretion and assembly of Sap and EA1. S-layer pro
Style APA, Harvard, Vancouver, ISO itp.
47

Carr, Jr., Marcus E., and Sheryl L. Zekert. "Protein S and C4b-Binding Protein Levels in Patients with Stroke: Implications for Protein S Regulation." Pathophysiology of Haemostasis and Thrombosis 23, no. 3 (1993): 159–67. http://dx.doi.org/10.1159/000216869.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
48

Malm, J., X. H. He, A. Bjartell, L. Shen, P. A. Abrahamsson, and B. Dahlbäck. "Vitamin K-dependent protein S in Leydig cells of human testis." Biochemical Journal 302, no. 3 (1994): 845–50. http://dx.doi.org/10.1042/bj3020845.

Pełny tekst źródła
Streszczenie:
Protein S is an anticoagulant plasma protein, functioning as a cofactor to activated protein C in the regulation of blood coagulation. In addition, protein S forms a complex with the complement regulatory protein, C4b-binding protein. Protein S is unique among the vitamin K-dependent proteins in being structurally similar to androgen binding proteins. Protein S immunoreactivity was demonstrated in Leydig cells of human testis. In Northern blotting experiments, the presence of protein S mRNA in human testis tissue could be shown. In situ hybridization experiments localized protein S mRNA to the
Style APA, Harvard, Vancouver, ISO itp.
49

Chang, Glenn T. G., Bart H. A. Maas, Hans K. Ploos van Amstel, Pieter H. Reitsma, Rogier M. Bertina, and Bonno N. Bouma. "Studies of the Interaction between Human Protein S and Human C4b-Binding Protein Using Deletion Variants of Recombinant Human Protein S." Thrombosis and Haemostasis 71, no. 04 (1994): 461–67. http://dx.doi.org/10.1055/s-0038-1642461.

Pełny tekst źródła
Streszczenie:
SummaryHuman protein S interacts noncovalently with human C4b-binding protein (C4BP). We have studied this interaction using deletion variants of recombinant human protein S. Two deletion variants were constructed by restriction enzyme digestion and in vitro site-specific mutagenesis of the human protein S cDNA. The variants were stably expressed in Cl27 cells. Recombinant proteins were purified using Fast Flow Q anion-exchange chromatography. The activated protein C (APC) cofactor activity, C4BP binding properties and reactivity to different monoclonal antibodies against human protein S were
Style APA, Harvard, Vancouver, ISO itp.
50

Smith, Donald B., Lloyd C. Berger, and Alan G. Wildeman. "Modified glutathione S-transferase fusion proteins for simplified analysis of protein - protein interactions." Nucleic Acids Research 21, no. 2 (1993): 359–60. http://dx.doi.org/10.1093/nar/21.2.359.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!